| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Spyre Therapeutics, Inc. (SYRE) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 23 sells. SYRE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 581.7K | $60.70M | -15,000 | |
| CFO | 344.9K | $35.99M | -7,500 | |
| Other | 140.0K | $14.61M | - | |
| Dir | 68.6K | $7.16M | - | |
| Dir | 8.0K | $837.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $95.51 | $1,432,705.05 | -0.5% | - | - | |
| Aug 3, 2026 | Burrows Scott L73 | Chief Financial Officer | Sale+OE | 7,500 | $95.57 | $716,771.00 | -2.5% | - | - | |
| Jul 1, 2026 | Sloan Sheldon | Chief Medical Officer | Sale+OE | 8,334 | $87.70 | $730,895.56 | -82.0% | - | - | |
| Jul 1, 2026 | Burrows Scott L73 | Chief Financial Officer | Sale+OE | 7,500 | $87.74 | $658,039.50 | -3.7% | - | - | |
| Jul 1, 2026 | Turtle Cameron | Chief Executive Officer | Sell | 15,000 | $87.69 | $1,315,346.42 | -0.8% | - | - | |
| Jun 25, 2026 | Burrows Scott L73 | Chief Financial Officer | Sale+OE | 15,000 | $87.13 | $1,307,000.00 | -6.8% | - | - | |
| Jun 23, 2026 | Fairmount Funds Management LLC74 | Director | Sell | 4,684,781 | $85.31 | $399,658,667.11 | -100% | - | - | |
| Jun 22, 2026 | Henderson Michael Thomas57 | Director | Sell | 20,000 | $100.00 | $2,000,000.00 | -22.6% | - | - | |
| Jun 3, 2026 | Sloan Sheldon | Chief Medical Officer | Sale+OE | 8,333 | $75.00 | $624,975.00 | -100% | - | - | |
| Jun 1, 2026 | Burrows Scott L73 | Chief Financial Officer | Sale+OE | 7,500 | $71.06 | $532,936.98 | -2.4% | - | - |